In a new collaboration, Race Against Dementia (RAD) and Rosetrees are fuelling pioneering medical research with a £3.75 million initiative to identify the UK’s most promising dementia research leaders who will build talented research teams. The elite RAD Teams will identify causes, develop prevention strategies and determine treatments for dementia.
Dementia impacts memory, thinking and behaviour and includes Alzheimer’s disease, frontotemporal dementia, vascular dementia and Lewy body dementia. Over 55 million people worldwide have dementia. Every year, there are nearly 10 million new cases.
“A mindset and work ethic we believe can be applied to a team of dementia researchers”
“Formula 1 teams are relentless in their drive to succeed – collaborating to achieve a common goal. It’s a mindset and work ethic we believe can be applied to a team of dementia researchers. I hope these new dementia research teams will speed up progress and get results.” ~ Sir Jackie Stewart OBE
The programme targets high-calibre researchers with outstanding ideas and transformative approaches. Awards of £750,000 – which can be used to recruit new staff, support current staff, purchase appropriate equipment and research costs – will commit five years of support. This provides a level of funding stability not normally seen in medical research.
RAD will train each team in a Formula 1-style mindset for focus and advancement and expose them to industrial practices. Rosetrees, a private UK charity supporting cutting edge medical research for more than 30 years, will spearhead the selection process.
“Rosetrees has championed brilliant new medical research ideas”
“Sir Jackie Stewart has very successfully championed Formula 1 racing, and Rosetrees has championed brilliant new medical research ideas. Both are familiar with ‘outside of the box’ approaches to create solutions to difficult problems and this will be a dynamic partnership in the quest for urgent life-changing advances.” ~ Richard Ross CBE, Chairman of Rosetrees
Formula 1® is using its global platform to help raise awareness for RAD and our drive to accelerate breakthroughs in treatments and cures for dementia. RAD currently supports early career researchers in the UK, Australia, the US, Europe and South Africa.
The online application window for initial expressions of interest is from 19th June to 4th September 2023. You can find out more and apply here. Successful applicants will be invited to submit full proposals between 30th October and 18th December 2023.